CL vs MRSN · P/E 34, rev $10.69B vs rev $40.5M
Colgate-Palmolive Company (CL) versus Mersana Therapeutics Inc (MRSN) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Mersana Therapeutics Inc (MRSN) is a biotechnology company listed on NASDAQ.
Latest reported CL revenue for 2026-06-30 was $10.69B. Net income was $1.34B. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Latest reported MRSN revenue for 2024-12-31 was $40.5M. Net income was -$69.2M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. MRSN currently screens at market cap $145.4M.
CL currently screens at market cap $70.88B and trailing P/E 34.3. MRSN currently screens at market cap $145.4M.
Not investment advice. Open the CL and MRSN stock pages for the full models.
Not investment advice.